NCT01521494View on ClinicalTrials.gov

PA21 Phase II Clinical Study in Hemodialysis Patients With Hyperphosphatemia

PHASE2CompletedINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

January 11, 2012

Primary Completion Date

July 3, 2012

Study Completion Date

July 3, 2012

Conditions
Chronic Kidney Disease Requiring Hemodialysis
Interventions
DRUG

PA21

DRUG

PA21

DRUG

PA21

DRUG

PA21

DRUG

Placebo

Trial Locations (1)

Unknown

Japan, Multiple Locations

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY